真实世界证据解决方案市场规模、份额、收益分析，按组件、按应用、按收益模式、按部署模式、按最终用户、按地区 - 行业预测，2024-2031 年

真实世界证据解决方案的全球市场规模预计到2022 年为15.4 亿美元，从2023 年的18 亿美元增长到2031 年的62.6 亿美元，预测期（2024-2031 年）预计将以16.9% 的复合年成长率增长。

真实世界证据 (RWE) 解决方案市场专注于使用真实环境中的资料来支援临床决策、监管核准和健康结果研究。由于对循证医学的需求不断增长以及对具有成本效益的医疗保健解决方案的需求，该市场正在经历显着增长。 RWE 解决方案利用电子健康记录、保险申请和病患登记的大型资料集集来产生见解，帮助了解治疗效果、安全概况和病患结果。由于慢性病的增加和对个人化医疗的日益重视，市场正在迅速扩大。资料分析的技术进步和相关人员之间日益加强的合作也推动了市场的成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 价格分析
• 技术分析
• 关税和监管状况
• 专利分析
• 客户和购买标准分析

真实世界证据解决方案市场：按组成部分

• 市场概况
• 服务
• 资料集
  • 异质资料集集
  • 临床设置资料集
  • 索赔资料集集
  • 药房资料集
  • 患者主导的资料集
  • 基于註册表的资料集
  • 综合资料集集

真实世界证据解决方案市场：按应用分类

• 市场概况
• 药物研发及核准
  • 肿瘤学
  • 心血管疾病
  • 神经病学
  • 免疫学
  • 其他治疗领域
• 医疗设备开发及核准
• 上市后监测
• 市场进入和报销/覆盖决策
• 临床和监管决策

真实世界证据解决方案市场：按收益模式划分

• 市场概况
• 付费使用制（基于价值的定价）
• 订阅

真实世界证据解决方案市场：依部署模式

• 市场概况
• 本地
• 云端基础

真实世界证据解决方案市场：按最终用户划分

• 市场概况
• 製药和医疗设备公司
• 医疗保健付款人
• 医疗服务提供方
• 其他最终用户

真实世界证据解决方案市场：按地区分類的规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Merative
• Icon Plc
• Parexel International Corporation
• Oracle Corporation
• Trinetx Llc
• Trinity
• Cognizant Technology Solutions Corporation
• Cegedim Health Data
• Verantos
• Datavant
• Tempus
• Flatiron Health
• Quantzig

Global Real-World Evidence Solutions Market size was valued at USD 1.54 billion in 2022 and is poised to grow from USD 1.80 billion in 2023 to USD 6.26 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

Real-World Evidence (RWE) Solutions Market focuses on the use of data from real-world settings to support clinical decision-making, regulatory approvals, and health outcomes research. This market has experienced substantial growth due to the increasing demand for evidence-based medicine and the need for cost-effective healthcare solutions. RWE solutions leverage large datasets from electronic health records, insurance claims, and patient registries to generate insights that help in understanding treatment effectiveness, safety profiles, and patient outcomes. With the rise in chronic diseases and the growing emphasis on personalized medicine, the market is expanding rapidly. Technological advancements in data analytics and an increasing number of collaborations between stakeholders are also fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Real-World Evidence Solutions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Real-World Evidence Solutions Market Segmental Analysis

Global Real-World Evidence Solutions Market is segmented on the basis of component, application, revenue model, end user, and region. By component, market is segmented into services, and data sets. By application, market is segmented into drug development & approvals, medical device development & approvals, post-market surveillance, market access & reimbursement/coverage decision-making, and clinical & regulatory decision-making. By revenue model, market is segmented into, pay per use (value-based pricing), and subscription. By deployment mode, market is segmented into on-premise, and cloud-based. By end user, market is segmented into pharmaceutical & medical device companies, healthcare payers, healthcare providers, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Real-World Evidence Solutions Market

One significant driver of the RWE Solutions Market is the growing demand for personalized medicine. Personalized medicine aims to tailor treatments to individual patient profiles, including genetic, environmental, and lifestyle factors. This approach relies heavily on real-world evidence to validate and optimize personalized treatment strategies. RWE provides insights into how different patient populations respond to treatments in real-world settings, enabling more accurate predictions of efficacy and safety. For instance, pharmaceutical companies utilize RWE to identify patient subgroups that may benefit most from specific therapies, leading to more targeted and effective interventions. As personalized medicine continues to evolve, the need for comprehensive real-world data to support these strategies drives demand for advanced RWE solutions.

Restraints in the Real-World Evidence Solutions Market

A major restraint in the RWE Solutions Market is the growing concern over data privacy and security. Real-world data, including sensitive health information, raises significant privacy issues and regulatory challenges. Stringent data protection regulations, such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the US, impose strict requirements on data handling, storage, and sharing. Compliance with these regulations can be complex and costly for organizations seeking to leverage real-world data. Additionally, breaches of data security can lead to severe legal and reputational consequences. Addressing these privacy concerns while ensuring data integrity and security remains a critical challenge for stakeholders in the RWE solutions market.

Market Trends of the Real-World Evidence Solutions Market

A prominent trend in the RWE Solutions Market is the increasing integration of artificial intelligence (AI) and machine learning (ML) technologies. AI and ML enhance the capability to analyze and interpret large volumes of real-world data, uncovering patterns and insights that might not be evident through traditional methods. These technologies facilitate advanced data analytics, enabling more accurate predictions of treatment outcomes, identification of new biomarkers, and optimization of clinical trial designs. For example, AI-driven algorithms can predict patient responses to treatments based on historical data, helping to personalize healthcare strategies and improve patient outcomes. The growing adoption of AI and ML is transforming the RWE landscape, making data analysis more efficient and actionable, and driving innovation across the healthcare industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Tariff And Regulatory Landscape
• Patent Analysis
• Customer & Buying Criteria Analysis

Real-World Evidence Solutions Market, By Component

• Market Overview
• Services
• Data Sets
  • Disparate Data Sets
  • Clinical Settings Data Sets
  • Claims Data Sets
  • Pharmacy Data Sets
  • Patient-Powered Data Sets
  • Registry-Based Data Sets
  • Integrated Data Sets

Real-World Evidence Solutions Market, By Application

• Market Overview
• Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Other Therapeutic Areas
• Medical Device Development & Approvals
• Post-Market Surveillance
• Market Access & Reimbursement/Coverage Decision-Making
• Clinical & Regulatory Decision-Making

Real-World Evidence Solutions Market, By Revenue Model

• Market Overview
• Pay Per Use (Value-Based Pricing)
• Subscription

Real-World Evidence Solutions Market, By Deployment Mode

• Market Overview
• On-Premise
• Cloud-Based

Real-World Evidence Solutions Market, By End User

• Market Overview
• Pharmaceutical & Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users

Real-World Evidence Solutions Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Merative
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icon Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinetx Llc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant Technology Solutions Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegedim Health Data
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verantos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Datavant
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantzig
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments